Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.
Lustig Y, Gonen T, Meltzer L, Gilboa M, Indenbaum V, Cohen C, Amit S, Jaber H, Doolman R, Asraf K, Rubin C, Fluss R, Mendelson E, Freedman L, Regev-Yochay G, Kreiss Y.
Lustig Y, et al.
Nat Immunol. 2022 Jun;23(6):940-946. doi: 10.1038/s41590-022-01212-3. Epub 2022 May 9.
Nat Immunol. 2022.
PMID: 35534723